nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Etoposide—brain cancer	0.151	0.214	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—brain cancer	0.113	0.16	CbGbCtD
Ezetimibe—ABCC2—Carboplatin—brain cancer	0.0816	0.116	CbGbCtD
Ezetimibe—ABCG2—Carboplatin—brain cancer	0.0738	0.105	CbGbCtD
Ezetimibe—ABCC2—Etoposide—brain cancer	0.0685	0.0971	CbGbCtD
Ezetimibe—CYP3A4—Temozolomide—brain cancer	0.0651	0.0923	CbGbCtD
Ezetimibe—ABCG2—Etoposide—brain cancer	0.062	0.0878	CbGbCtD
Ezetimibe—CYP3A4—Lomustine—brain cancer	0.0554	0.0785	CbGbCtD
Ezetimibe—ABCB1—Etoposide—brain cancer	0.0223	0.0317	CbGbCtD
Ezetimibe—CYP3A4—Etoposide—brain cancer	0.0134	0.019	CbGbCtD
Ezetimibe—ABCG5—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0059	0.0938	CbGpPWpGaD
Ezetimibe—ANPEP—Glutathione metabolism—IDH1—brain cancer	0.00569	0.0905	CbGpPWpGaD
Ezetimibe—UGT2B15—Tamoxifen metabolism—CYP2C9—brain cancer	0.00507	0.0807	CbGpPWpGaD
Ezetimibe—ABCG5—endocrine gland—brain cancer	0.00435	0.0917	CbGeAlD
Ezetimibe—NPC1L1—endocrine gland—brain cancer	0.00409	0.0862	CbGeAlD
Ezetimibe—ABCG8—endocrine gland—brain cancer	0.00388	0.0817	CbGeAlD
Ezetimibe—UGT2B7—Tamoxifen metabolism—CYP2C9—brain cancer	0.00231	0.0367	CbGpPWpGaD
Ezetimibe—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00194	0.0308	CbGpPWpGaD
Ezetimibe—SOAT1—gonad—brain cancer	0.00185	0.039	CbGeAlD
Ezetimibe—SOAT1—pituitary gland—brain cancer	0.00181	0.0381	CbGeAlD
Ezetimibe—UGT1A3—endocrine gland—brain cancer	0.00173	0.0365	CbGeAlD
Ezetimibe—ANPEP—pituitary gland—brain cancer	0.00173	0.0364	CbGeAlD
Ezetimibe—ANPEP—medulla oblongata—brain cancer	0.00167	0.0352	CbGeAlD
Ezetimibe—ABCC3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00165	0.0262	CbGpPWpGaD
Ezetimibe—UGT2B15—endocrine gland—brain cancer	0.00163	0.0343	CbGeAlD
Ezetimibe—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00157	0.025	CbGpPWpGaD
Ezetimibe—SOAT1—spinal cord—brain cancer	0.00156	0.0328	CbGeAlD
Ezetimibe—Flunarizine—CYP2C9—brain cancer	0.00144	1	CrCbGaD
Ezetimibe—SOAT1—endocrine gland—brain cancer	0.0014	0.0295	CbGeAlD
Ezetimibe—SOAT1—head—brain cancer	0.00138	0.0291	CbGeAlD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	0.00137	0.0217	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDK6—brain cancer	0.00135	0.0214	CbGpPWpGaD
Ezetimibe—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00134	0.0213	CbGpPWpGaD
Ezetimibe—ANPEP—endocrine gland—brain cancer	0.00134	0.0282	CbGeAlD
Ezetimibe—Eosinophilia—Procarbazine—brain cancer	0.00133	0.00731	CcSEcCtD
Ezetimibe—ANPEP—head—brain cancer	0.00132	0.0279	CbGeAlD
Ezetimibe—Pancreatitis—Procarbazine—brain cancer	0.00132	0.00724	CcSEcCtD
Ezetimibe—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00131	0.0208	CbGpPWpGaD
Ezetimibe—Phosphatase alkaline increased—Temozolomide—brain cancer	0.0013	0.00711	CcSEcCtD
Ezetimibe—SOAT1—central nervous system—brain cancer	0.00126	0.0266	CbGeAlD
Ezetimibe—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00125	0.0198	CbGpPWpGaD
Ezetimibe—SOAT1—cerebellum—brain cancer	0.00123	0.026	CbGeAlD
Ezetimibe—Photosensitivity reaction—Procarbazine—brain cancer	0.00123	0.00674	CcSEcCtD
Ezetimibe—ANPEP—central nervous system—brain cancer	0.00121	0.0254	CbGeAlD
Ezetimibe—Infection—Lomustine—brain cancer	0.0012	0.00657	CcSEcCtD
Ezetimibe—Thrombocytopenia—Lomustine—brain cancer	0.00118	0.00647	CcSEcCtD
Ezetimibe—Pain—Carboplatin—brain cancer	0.00118	0.00646	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Procarbazine—brain cancer	0.00118	0.00645	CcSEcCtD
Ezetimibe—Jaundice—Procarbazine—brain cancer	0.00117	0.00642	CcSEcCtD
Ezetimibe—Body temperature increased—Carboplatin—brain cancer	0.00109	0.00597	CcSEcCtD
Ezetimibe—Breast disorder—Hydroxyurea—brain cancer	0.00109	0.00597	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00108	0.00594	CcSEcCtD
Ezetimibe—Inflammation—Etoposide—brain cancer	0.00107	0.00587	CcSEcCtD
Ezetimibe—Decreased appetite—Lomustine—brain cancer	0.00105	0.00575	CcSEcCtD
Ezetimibe—Hepatic failure—Temozolomide—brain cancer	0.00105	0.00575	CcSEcCtD
Ezetimibe—Phosphatase alkaline increased—Etoposide—brain cancer	0.00104	0.00569	CcSEcCtD
Ezetimibe—Amnesia—Carmustine—brain cancer	0.00104	0.00569	CcSEcCtD
Ezetimibe—Pancreatitis—Hydroxyurea—brain cancer	0.00102	0.0056	CcSEcCtD
Ezetimibe—Hot flush—Temozolomide—brain cancer	0.00101	0.00552	CcSEcCtD
Ezetimibe—Amnesia—Temozolomide—brain cancer	0.001	0.0055	CcSEcCtD
Ezetimibe—SOAT1—brain—brain cancer	0.001	0.0211	CbGeAlD
Ezetimibe—Flushing—Procarbazine—brain cancer	0.001	0.00548	CcSEcCtD
Ezetimibe—Menopausal symptoms—Temozolomide—brain cancer	0.000999	0.00547	CcSEcCtD
Ezetimibe—UGT2B7—endocrine gland—brain cancer	0.000995	0.021	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—HES1—brain cancer	0.000992	0.0158	CbGpPWpGaD
Ezetimibe—ANPEP—brain—brain cancer	0.000959	0.0202	CbGeAlD
Ezetimibe—Body temperature increased—Lomustine—brain cancer	0.000954	0.00523	CcSEcCtD
Ezetimibe—Alopecia—Procarbazine—brain cancer	0.000953	0.00522	CcSEcCtD
Ezetimibe—UGT2B15—Biological oxidations—CYP2C9—brain cancer	0.000943	0.015	CbGpPWpGaD
Ezetimibe—Infestation NOS—Hydroxyurea—brain cancer	0.00093	0.00509	CcSEcCtD
Ezetimibe—Infestation—Hydroxyurea—brain cancer	0.00093	0.00509	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000911	0.00499	CcSEcCtD
Ezetimibe—Liver function test abnormal—Carmustine—brain cancer	0.000901	0.00493	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000879	0.00482	CcSEcCtD
Ezetimibe—Anaemia—Procarbazine—brain cancer	0.000868	0.00475	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000867	0.00475	CcSEcCtD
Ezetimibe—Muscular weakness—Carmustine—brain cancer	0.00086	0.00471	CcSEcCtD
Ezetimibe—Breast disorder—Temozolomide—brain cancer	0.000852	0.00467	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000849	0.00465	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000849	0.0135	CbGpPWpGaD
Ezetimibe—UGT1A1—endocrine gland—brain cancer	0.000846	0.0178	CbGeAlD
Ezetimibe—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000831	0.00455	CcSEcCtD
Ezetimibe—Muscular weakness—Temozolomide—brain cancer	0.000831	0.00455	CcSEcCtD
Ezetimibe—Cough—Procarbazine—brain cancer	0.000819	0.00449	CcSEcCtD
Ezetimibe—Hypertension—Procarbazine—brain cancer	0.000811	0.00444	CcSEcCtD
Ezetimibe—Arthralgia—Procarbazine—brain cancer	0.000799	0.00438	CcSEcCtD
Ezetimibe—Myalgia—Procarbazine—brain cancer	0.000799	0.00438	CcSEcCtD
Ezetimibe—Dry mouth—Procarbazine—brain cancer	0.000782	0.00428	CcSEcCtD
Ezetimibe—Confusional state—Procarbazine—brain cancer	0.000773	0.00423	CcSEcCtD
Ezetimibe—Vomiting—Lomustine—brain cancer	0.000767	0.0042	CcSEcCtD
Ezetimibe—Infection—Procarbazine—brain cancer	0.000761	0.00417	CcSEcCtD
Ezetimibe—Angiopathy—Hydroxyurea—brain cancer	0.000757	0.00415	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Temozolomide—brain cancer	0.000757	0.00415	CcSEcCtD
Ezetimibe—Erectile dysfunction—Temozolomide—brain cancer	0.00075	0.00411	CcSEcCtD
Ezetimibe—Thrombocytopenia—Procarbazine—brain cancer	0.00075	0.00411	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Temozolomide—brain cancer	0.000744	0.00407	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000738	0.0117	CbGpPWpGaD
Ezetimibe—Alopecia—Hydroxyurea—brain cancer	0.000738	0.00404	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Carmustine—brain cancer	0.000737	0.00404	CcSEcCtD
Ezetimibe—Erythema—Hydroxyurea—brain cancer	0.000727	0.00398	CcSEcCtD
Ezetimibe—Infestation NOS—Temozolomide—brain cancer	0.000726	0.00398	CcSEcCtD
Ezetimibe—Infestation—Temozolomide—brain cancer	0.000726	0.00398	CcSEcCtD
Ezetimibe—Nausea—Lomustine—brain cancer	0.000717	0.00393	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Temozolomide—brain cancer	0.000712	0.0039	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—S100A10—brain cancer	0.00071	0.0113	CbGpPWpGaD
Ezetimibe—SLCO1B1—endocrine gland—brain cancer	0.000704	0.0148	CbGeAlD
Ezetimibe—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000698	0.00382	CcSEcCtD
Ezetimibe—Insomnia—Procarbazine—brain cancer	0.000693	0.0038	CcSEcCtD
Ezetimibe—UGT1A1—Irinotecan Pathway—APC—brain cancer	0.000689	0.0109	CbGpPWpGaD
Ezetimibe—Paraesthesia—Procarbazine—brain cancer	0.000688	0.00377	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Temozolomide—brain cancer	0.000687	0.00376	CcSEcCtD
Ezetimibe—Sinusitis—Temozolomide—brain cancer	0.000682	0.00373	CcSEcCtD
Ezetimibe—Cramp muscle—Etoposide—brain cancer	0.000679	0.00372	CcSEcCtD
Ezetimibe—Ill-defined disorder—Hydroxyurea—brain cancer	0.000674	0.00369	CcSEcCtD
Ezetimibe—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000672	0.0107	CbGpPWpGaD
Ezetimibe—Anaemia—Hydroxyurea—brain cancer	0.000672	0.00368	CcSEcCtD
Ezetimibe—ABCC3—endocrine gland—brain cancer	0.000668	0.0141	CbGeAlD
Ezetimibe—Decreased appetite—Procarbazine—brain cancer	0.000666	0.00365	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Etoposide—brain cancer	0.000665	0.00364	CcSEcCtD
Ezetimibe—Oedema peripheral—Carmustine—brain cancer	0.000665	0.00364	CcSEcCtD
Ezetimibe—Connective tissue disorder—Carmustine—brain cancer	0.000663	0.00363	CcSEcCtD
Ezetimibe—Fatigue—Procarbazine—brain cancer	0.000661	0.00362	CcSEcCtD
Ezetimibe—ABCC3—head—brain cancer	0.000659	0.0139	CbGeAlD
Ezetimibe—Malaise—Hydroxyurea—brain cancer	0.000655	0.00359	CcSEcCtD
Ezetimibe—Pain—Procarbazine—brain cancer	0.000655	0.00359	CcSEcCtD
Ezetimibe—Constipation—Procarbazine—brain cancer	0.000655	0.00359	CcSEcCtD
Ezetimibe—Hepatitis—Temozolomide—brain cancer	0.000652	0.00357	CcSEcCtD
Ezetimibe—Pharyngitis—Temozolomide—brain cancer	0.000647	0.00355	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000643	0.0102	CbGpPWpGaD
Ezetimibe—Oedema peripheral—Temozolomide—brain cancer	0.000642	0.00352	CcSEcCtD
Ezetimibe—Connective tissue disorder—Temozolomide—brain cancer	0.000641	0.00351	CcSEcCtD
Ezetimibe—Feeling abnormal—Procarbazine—brain cancer	0.000631	0.00346	CcSEcCtD
Ezetimibe—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000631	0.01	CbGpPWpGaD
Ezetimibe—ABCB1—blood vessel—brain cancer	0.000627	0.0132	CbGeAlD
Ezetimibe—Gastrointestinal pain—Procarbazine—brain cancer	0.000627	0.00343	CcSEcCtD
Ezetimibe—Flushing—Carmustine—brain cancer	0.000626	0.00343	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000621	0.00986	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000619	0.00984	CbGpPWpGaD
Ezetimibe—ABCG2—telencephalon—brain cancer	0.000617	0.013	CbGeAlD
Ezetimibe—Erythema multiforme—Temozolomide—brain cancer	0.000617	0.00338	CcSEcCtD
Ezetimibe—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000615	0.00978	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000614	0.00337	CcSEcCtD
Ezetimibe—Discomfort—Hydroxyurea—brain cancer	0.000611	0.00335	CcSEcCtD
Ezetimibe—Urticaria—Procarbazine—brain cancer	0.000609	0.00333	CcSEcCtD
Ezetimibe—Body temperature increased—Procarbazine—brain cancer	0.000606	0.00332	CcSEcCtD
Ezetimibe—Abdominal pain—Procarbazine—brain cancer	0.000606	0.00332	CcSEcCtD
Ezetimibe—Flushing—Temozolomide—brain cancer	0.000605	0.00332	CcSEcCtD
Ezetimibe—ABCC3—central nervous system—brain cancer	0.000602	0.0127	CbGeAlD
Ezetimibe—Alopecia—Carmustine—brain cancer	0.000596	0.00327	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN2A—brain cancer	0.000595	0.00945	CbGpPWpGaD
Ezetimibe—Angiopathy—Temozolomide—brain cancer	0.000592	0.00324	CcSEcCtD
Ezetimibe—Mental disorder—Carmustine—brain cancer	0.000591	0.00324	CcSEcCtD
Ezetimibe—Infection—Hydroxyurea—brain cancer	0.000589	0.00323	CcSEcCtD
Ezetimibe—Immune system disorder—Temozolomide—brain cancer	0.000589	0.00323	CcSEcCtD
Ezetimibe—Mediastinal disorder—Temozolomide—brain cancer	0.000588	0.00322	CcSEcCtD
Ezetimibe—Erythema—Carmustine—brain cancer	0.000587	0.00322	CcSEcCtD
Ezetimibe—Malnutrition—Carmustine—brain cancer	0.000587	0.00322	CcSEcCtD
Ezetimibe—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000586	0.00931	CbGpPWpGaD
Ezetimibe—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000584	0.00929	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Hydroxyurea—brain cancer	0.000582	0.00319	CcSEcCtD
Ezetimibe—Infestation—Etoposide—brain cancer	0.000581	0.00318	CcSEcCtD
Ezetimibe—Infestation NOS—Etoposide—brain cancer	0.000581	0.00318	CcSEcCtD
Ezetimibe—Thrombocytopenia—Hydroxyurea—brain cancer	0.000581	0.00318	CcSEcCtD
Ezetimibe—Alopecia—Temozolomide—brain cancer	0.000576	0.00316	CcSEcCtD
Ezetimibe—Skin disorder—Hydroxyurea—brain cancer	0.000576	0.00316	CcSEcCtD
Ezetimibe—Mental disorder—Temozolomide—brain cancer	0.000571	0.00313	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Etoposide—brain cancer	0.00057	0.00312	CcSEcCtD
Ezetimibe—Back pain—Carmustine—brain cancer	0.000568	0.00311	CcSEcCtD
Ezetimibe—Erythema—Temozolomide—brain cancer	0.000568	0.00311	CcSEcCtD
Ezetimibe—Malnutrition—Temozolomide—brain cancer	0.000568	0.00311	CcSEcCtD
Ezetimibe—Jaundice—Etoposide—brain cancer	0.000567	0.0031	CcSEcCtD
Ezetimibe—Hypersensitivity—Procarbazine—brain cancer	0.000565	0.00309	CcSEcCtD
Ezetimibe—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000552	0.00877	CbGpPWpGaD
Ezetimibe—Asthenia—Procarbazine—brain cancer	0.00055	0.00301	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Etoposide—brain cancer	0.00055	0.00301	CcSEcCtD
Ezetimibe—Back pain—Temozolomide—brain cancer	0.000549	0.00301	CcSEcCtD
Ezetimibe—Anaemia—Carmustine—brain cancer	0.000543	0.00297	CcSEcCtD
Ezetimibe—Pruritus—Procarbazine—brain cancer	0.000542	0.00297	CcSEcCtD
Ezetimibe—ABCC2—endocrine gland—brain cancer	0.000534	0.0112	CbGeAlD
Ezetimibe—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000531	0.00844	CbGpPWpGaD
Ezetimibe—Dyspnoea—Hydroxyurea—brain cancer	0.000529	0.0029	CcSEcCtD
Ezetimibe—Ill-defined disorder—Temozolomide—brain cancer	0.000527	0.00289	CcSEcCtD
Ezetimibe—Anaemia—Temozolomide—brain cancer	0.000525	0.00287	CcSEcCtD
Ezetimibe—Diarrhoea—Procarbazine—brain cancer	0.000524	0.00287	CcSEcCtD
Ezetimibe—Dyspepsia—Hydroxyurea—brain cancer	0.000522	0.00286	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000521	0.00829	CbGpPWpGaD
Ezetimibe—Angioedema—Temozolomide—brain cancer	0.000519	0.00284	CcSEcCtD
Ezetimibe—Decreased appetite—Hydroxyurea—brain cancer	0.000516	0.00282	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000512	0.0028	CcSEcCtD
Ezetimibe—Malaise—Temozolomide—brain cancer	0.000512	0.0028	CcSEcCtD
Ezetimibe—Fatigue—Hydroxyurea—brain cancer	0.000511	0.0028	CcSEcCtD
Ezetimibe—Hypertension—Carmustine—brain cancer	0.000507	0.00278	CcSEcCtD
Ezetimibe—Constipation—Hydroxyurea—brain cancer	0.000507	0.00278	CcSEcCtD
Ezetimibe—Pain—Hydroxyurea—brain cancer	0.000507	0.00278	CcSEcCtD
Ezetimibe—Dizziness—Procarbazine—brain cancer	0.000507	0.00278	CcSEcCtD
Ezetimibe—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000505	0.00803	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CCND1—brain cancer	0.000503	0.00799	CbGpPWpGaD
Ezetimibe—ABCG2—pituitary gland—brain cancer	0.000502	0.0106	CbGeAlD
Ezetimibe—Palpitations—Temozolomide—brain cancer	0.000502	0.00275	CcSEcCtD
Ezetimibe—Myalgia—Carmustine—brain cancer	0.0005	0.00274	CcSEcCtD
Ezetimibe—Chest pain—Carmustine—brain cancer	0.0005	0.00274	CcSEcCtD
Ezetimibe—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000498	0.00792	CbGpPWpGaD
Ezetimibe—Cough—Temozolomide—brain cancer	0.000495	0.00271	CcSEcCtD
Ezetimibe—Erythema multiforme—Etoposide—brain cancer	0.000493	0.0027	CcSEcCtD
Ezetimibe—ANPEP—Peptide hormone metabolism—CTNNB1—brain cancer	0.000493	0.00784	CbGpPWpGaD
Ezetimibe—Hypertension—Temozolomide—brain cancer	0.00049	0.00269	CcSEcCtD
Ezetimibe—Feeling abnormal—Hydroxyurea—brain cancer	0.000489	0.00268	CcSEcCtD
Ezetimibe—Vomiting—Procarbazine—brain cancer	0.000487	0.00267	CcSEcCtD
Ezetimibe—ABCG2—medulla oblongata—brain cancer	0.000485	0.0102	CbGeAlD
Ezetimibe—Flushing—Etoposide—brain cancer	0.000484	0.00265	CcSEcCtD
Ezetimibe—Confusional state—Carmustine—brain cancer	0.000483	0.00265	CcSEcCtD
Ezetimibe—Myalgia—Temozolomide—brain cancer	0.000483	0.00265	CcSEcCtD
Ezetimibe—Arthralgia—Temozolomide—brain cancer	0.000483	0.00265	CcSEcCtD
Ezetimibe—Rash—Procarbazine—brain cancer	0.000483	0.00265	CcSEcCtD
Ezetimibe—Dermatitis—Procarbazine—brain cancer	0.000483	0.00264	CcSEcCtD
Ezetimibe—Headache—Procarbazine—brain cancer	0.00048	0.00263	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00048	0.00263	CcSEcCtD
Ezetimibe—ABCC3—brain—brain cancer	0.000478	0.0101	CbGeAlD
Ezetimibe—Discomfort—Temozolomide—brain cancer	0.000477	0.00262	CcSEcCtD
Ezetimibe—Infection—Carmustine—brain cancer	0.000476	0.00261	CcSEcCtD
Ezetimibe—Angiopathy—Etoposide—brain cancer	0.000473	0.00259	CcSEcCtD
Ezetimibe—Dry mouth—Temozolomide—brain cancer	0.000473	0.00259	CcSEcCtD
Ezetimibe—Immune system disorder—Etoposide—brain cancer	0.000471	0.00258	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00047	0.00748	CbGpPWpGaD
Ezetimibe—Mediastinal disorder—Etoposide—brain cancer	0.00047	0.00258	CcSEcCtD
Ezetimibe—Thrombocytopenia—Carmustine—brain cancer	0.000469	0.00257	CcSEcCtD
Ezetimibe—Body temperature increased—Hydroxyurea—brain cancer	0.000469	0.00257	CcSEcCtD
Ezetimibe—Confusional state—Temozolomide—brain cancer	0.000467	0.00256	CcSEcCtD
Ezetimibe—Anaphylactic shock—Temozolomide—brain cancer	0.000463	0.00254	CcSEcCtD
Ezetimibe—Alopecia—Etoposide—brain cancer	0.000461	0.00253	CcSEcCtD
Ezetimibe—Infection—Temozolomide—brain cancer	0.00046	0.00252	CcSEcCtD
Ezetimibe—Nausea—Procarbazine—brain cancer	0.000455	0.00249	CcSEcCtD
Ezetimibe—Nervous system disorder—Temozolomide—brain cancer	0.000454	0.00249	CcSEcCtD
Ezetimibe—Thrombocytopenia—Temozolomide—brain cancer	0.000454	0.00249	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000453	0.0072	CbGpPWpGaD
Ezetimibe—Skin disorder—Temozolomide—brain cancer	0.00045	0.00247	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000443	0.00705	CbGpPWpGaD
Ezetimibe—ABCG2—midbrain—brain cancer	0.000443	0.00933	CbGeAlD
Ezetimibe—Back pain—Etoposide—brain cancer	0.000439	0.00241	CcSEcCtD
Ezetimibe—Hypersensitivity—Hydroxyurea—brain cancer	0.000437	0.00239	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Carmustine—brain cancer	0.000437	0.00239	CcSEcCtD
Ezetimibe—Muscle spasms—Etoposide—brain cancer	0.000437	0.00239	CcSEcCtD
Ezetimibe—Insomnia—Carmustine—brain cancer	0.000434	0.00238	CcSEcCtD
Ezetimibe—ABCG2—spinal cord—brain cancer	0.000432	0.00911	CbGeAlD
Ezetimibe—Paraesthesia—Carmustine—brain cancer	0.00043	0.00236	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.00043	0.00683	CbGpPWpGaD
Ezetimibe—Dyspnoea—Carmustine—brain cancer	0.000427	0.00234	CcSEcCtD
Ezetimibe—Asthenia—Hydroxyurea—brain cancer	0.000425	0.00233	CcSEcCtD
Ezetimibe—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000424	0.00674	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000422	0.00231	CcSEcCtD
Ezetimibe—Ill-defined disorder—Etoposide—brain cancer	0.000421	0.00231	CcSEcCtD
Ezetimibe—Anaemia—Etoposide—brain cancer	0.00042	0.0023	CcSEcCtD
Ezetimibe—Insomnia—Temozolomide—brain cancer	0.000419	0.0023	CcSEcCtD
Ezetimibe—Decreased appetite—Carmustine—brain cancer	0.000417	0.00228	CcSEcCtD
Ezetimibe—Paraesthesia—Temozolomide—brain cancer	0.000416	0.00228	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Carmustine—brain cancer	0.000414	0.00227	CcSEcCtD
Ezetimibe—Dyspnoea—Temozolomide—brain cancer	0.000413	0.00226	CcSEcCtD
Ezetimibe—Constipation—Carmustine—brain cancer	0.00041	0.00225	CcSEcCtD
Ezetimibe—Pain—Carmustine—brain cancer	0.00041	0.00225	CcSEcCtD
Ezetimibe—Malaise—Etoposide—brain cancer	0.00041	0.00224	CcSEcCtD
Ezetimibe—Dyspepsia—Temozolomide—brain cancer	0.000408	0.00223	CcSEcCtD
Ezetimibe—Diarrhoea—Hydroxyurea—brain cancer	0.000406	0.00222	CcSEcCtD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000404	0.00642	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—MYC—brain cancer	0.000403	0.00641	CbGpPWpGaD
Ezetimibe—Decreased appetite—Temozolomide—brain cancer	0.000403	0.00221	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Temozolomide—brain cancer	0.0004	0.00219	CcSEcCtD
Ezetimibe—Fatigue—Temozolomide—brain cancer	0.000399	0.00219	CcSEcCtD
Ezetimibe—Cough—Etoposide—brain cancer	0.000396	0.00217	CcSEcCtD
Ezetimibe—Pain—Temozolomide—brain cancer	0.000396	0.00217	CcSEcCtD
Ezetimibe—Constipation—Temozolomide—brain cancer	0.000396	0.00217	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000395	0.00628	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Carmustine—brain cancer	0.000395	0.00216	CcSEcCtD
Ezetimibe—Hypertension—Etoposide—brain cancer	0.000392	0.00215	CcSEcCtD
Ezetimibe—Dizziness—Hydroxyurea—brain cancer	0.000392	0.00215	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Carmustine—brain cancer	0.000392	0.00215	CcSEcCtD
Ezetimibe—Chest pain—Etoposide—brain cancer	0.000387	0.00212	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000384	0.0021	CcSEcCtD
Ezetimibe—Discomfort—Etoposide—brain cancer	0.000382	0.00209	CcSEcCtD
Ezetimibe—Feeling abnormal—Temozolomide—brain cancer	0.000382	0.00209	CcSEcCtD
Ezetimibe—Body temperature increased—Carmustine—brain cancer	0.000379	0.00208	CcSEcCtD
Ezetimibe—Abdominal pain—Carmustine—brain cancer	0.000379	0.00208	CcSEcCtD
Ezetimibe—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000379	0.00602	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Temozolomide—brain cancer	0.000379	0.00208	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—CYP2C9—brain cancer	0.000378	0.00601	CbGpPWpGaD
Ezetimibe—Vomiting—Hydroxyurea—brain cancer	0.000377	0.00207	CcSEcCtD
Ezetimibe—Rash—Hydroxyurea—brain cancer	0.000374	0.00205	CcSEcCtD
Ezetimibe—Confusional state—Etoposide—brain cancer	0.000374	0.00205	CcSEcCtD
Ezetimibe—Dermatitis—Hydroxyurea—brain cancer	0.000374	0.00205	CcSEcCtD
Ezetimibe—Headache—Hydroxyurea—brain cancer	0.000372	0.00204	CcSEcCtD
Ezetimibe—Anaphylactic shock—Etoposide—brain cancer	0.000371	0.00203	CcSEcCtD
Ezetimibe—Infection—Etoposide—brain cancer	0.000368	0.00202	CcSEcCtD
Ezetimibe—Urticaria—Temozolomide—brain cancer	0.000368	0.00202	CcSEcCtD
Ezetimibe—Abdominal pain—Temozolomide—brain cancer	0.000366	0.00201	CcSEcCtD
Ezetimibe—Body temperature increased—Temozolomide—brain cancer	0.000366	0.00201	CcSEcCtD
Ezetimibe—Thrombocytopenia—Etoposide—brain cancer	0.000363	0.00199	CcSEcCtD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000361	0.00574	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00036	0.00573	CbGpPWpGaD
Ezetimibe—Skin disorder—Etoposide—brain cancer	0.00036	0.00197	CcSEcCtD
Ezetimibe—Hypersensitivity—Carmustine—brain cancer	0.000353	0.00194	CcSEcCtD
Ezetimibe—Nausea—Hydroxyurea—brain cancer	0.000352	0.00193	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—CYP2C9—brain cancer	0.000349	0.00555	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000344	0.00547	CbGpPWpGaD
Ezetimibe—Asthenia—Carmustine—brain cancer	0.000344	0.00188	CcSEcCtD
Ezetimibe—ABCG2—cerebellum—brain cancer	0.000343	0.00722	CbGeAlD
Ezetimibe—Hypersensitivity—Temozolomide—brain cancer	0.000341	0.00187	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000341	0.00542	CbGpPWpGaD
Ezetimibe—Paraesthesia—Etoposide—brain cancer	0.000333	0.00182	CcSEcCtD
Ezetimibe—Asthenia—Temozolomide—brain cancer	0.000332	0.00182	CcSEcCtD
Ezetimibe—Dyspnoea—Etoposide—brain cancer	0.000331	0.00181	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000328	0.00522	CbGpPWpGaD
Ezetimibe—Diarrhoea—Carmustine—brain cancer	0.000328	0.0018	CcSEcCtD
Ezetimibe—Pruritus—Temozolomide—brain cancer	0.000328	0.0018	CcSEcCtD
Ezetimibe—Decreased appetite—Etoposide—brain cancer	0.000322	0.00177	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—BSG—brain cancer	0.000321	0.00511	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Etoposide—brain cancer	0.00032	0.00175	CcSEcCtD
Ezetimibe—Fatigue—Etoposide—brain cancer	0.00032	0.00175	CcSEcCtD
Ezetimibe—Dizziness—Carmustine—brain cancer	0.000317	0.00174	CcSEcCtD
Ezetimibe—Pain—Etoposide—brain cancer	0.000317	0.00174	CcSEcCtD
Ezetimibe—Constipation—Etoposide—brain cancer	0.000317	0.00174	CcSEcCtD
Ezetimibe—Diarrhoea—Temozolomide—brain cancer	0.000317	0.00174	CcSEcCtD
Ezetimibe—Dizziness—Temozolomide—brain cancer	0.000306	0.00168	CcSEcCtD
Ezetimibe—Feeling abnormal—Etoposide—brain cancer	0.000305	0.00167	CcSEcCtD
Ezetimibe—Vomiting—Carmustine—brain cancer	0.000305	0.00167	CcSEcCtD
Ezetimibe—ABCB1—telencephalon—brain cancer	0.000304	0.00641	CbGeAlD
Ezetimibe—Gastrointestinal pain—Etoposide—brain cancer	0.000303	0.00166	CcSEcCtD
Ezetimibe—Rash—Carmustine—brain cancer	0.000302	0.00166	CcSEcCtD
Ezetimibe—Dermatitis—Carmustine—brain cancer	0.000302	0.00165	CcSEcCtD
Ezetimibe—Headache—Carmustine—brain cancer	0.0003	0.00165	CcSEcCtD
Ezetimibe—Vomiting—Temozolomide—brain cancer	0.000295	0.00161	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—brain cancer	0.000295	0.00161	CcSEcCtD
Ezetimibe—Abdominal pain—Etoposide—brain cancer	0.000293	0.00161	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—brain cancer	0.000293	0.00161	CcSEcCtD
Ezetimibe—Rash—Temozolomide—brain cancer	0.000292	0.0016	CcSEcCtD
Ezetimibe—Dermatitis—Temozolomide—brain cancer	0.000292	0.0016	CcSEcCtD
Ezetimibe—Headache—Temozolomide—brain cancer	0.00029	0.00159	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—CYP2C9—brain cancer	0.000286	0.00455	CbGpPWpGaD
Ezetimibe—Nausea—Carmustine—brain cancer	0.000285	0.00156	CcSEcCtD
Ezetimibe—ABCG2—brain—brain cancer	0.000278	0.00586	CbGeAlD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000277	0.0044	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—IDH1—brain cancer	0.000276	0.00439	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CYP2C9—brain cancer	0.000276	0.00438	CbGpPWpGaD
Ezetimibe—Nausea—Temozolomide—brain cancer	0.000275	0.00151	CcSEcCtD
Ezetimibe—Hypersensitivity—Etoposide—brain cancer	0.000273	0.0015	CcSEcCtD
Ezetimibe—CYP3A4—endocrine gland—brain cancer	0.000271	0.00571	CbGeAlD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000271	0.00431	CbGpPWpGaD
Ezetimibe—Asthenia—Etoposide—brain cancer	0.000266	0.00146	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—brain cancer	0.000262	0.00144	CcSEcCtD
Ezetimibe—ABCB1—gonad—brain cancer	0.000254	0.00535	CbGeAlD
Ezetimibe—Diarrhoea—Etoposide—brain cancer	0.000254	0.00139	CcSEcCtD
Ezetimibe—ABCB1—pituitary gland—brain cancer	0.000248	0.00522	CbGeAlD
Ezetimibe—Dizziness—Etoposide—brain cancer	0.000245	0.00134	CcSEcCtD
Ezetimibe—CYP3A4—central nervous system—brain cancer	0.000244	0.00515	CbGeAlD
Ezetimibe—ABCG8—Metabolism—BSG—brain cancer	0.000244	0.00387	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00024	0.00381	CbGpPWpGaD
Ezetimibe—ABCB1—medulla oblongata—brain cancer	0.000239	0.00504	CbGeAlD
Ezetimibe—Vomiting—Etoposide—brain cancer	0.000236	0.00129	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—BSG—brain cancer	0.000234	0.00373	CbGpPWpGaD
Ezetimibe—Rash—Etoposide—brain cancer	0.000234	0.00128	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—brain cancer	0.000234	0.00128	CcSEcCtD
Ezetimibe—Headache—Etoposide—brain cancer	0.000232	0.00127	CcSEcCtD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000229	0.00364	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000226	0.0036	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000225	0.00358	CbGpPWpGaD
Ezetimibe—Nausea—Etoposide—brain cancer	0.00022	0.00121	CcSEcCtD
Ezetimibe—ABCB1—midbrain—brain cancer	0.000219	0.0046	CbGeAlD
Ezetimibe—NPC1L1—Metabolism—ENO2—brain cancer	0.000218	0.00347	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000214	0.0034	CbGpPWpGaD
Ezetimibe—ABCB1—spinal cord—brain cancer	0.000213	0.00449	CbGeAlD
Ezetimibe—ABCG8—Metabolism—IDH1—brain cancer	0.000209	0.00333	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000207	0.00329	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—IDH1—brain cancer	0.000202	0.0032	CbGpPWpGaD
Ezetimibe—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000195	0.00309	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—brain cancer	0.000193	0.00307	CbGpPWpGaD
Ezetimibe—ABCB1—endocrine gland—brain cancer	0.000192	0.00404	CbGeAlD
Ezetimibe—ABCB1—head—brain cancer	0.000189	0.00399	CbGeAlD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000189	0.00301	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000187	0.00297	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000186	0.00295	CbGpPWpGaD
Ezetimibe—ABCB1—central nervous system—brain cancer	0.000173	0.00364	CbGeAlD
Ezetimibe—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000173	0.00274	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000172	0.00273	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000171	0.00271	CbGpPWpGaD
Ezetimibe—ABCB1—cerebellum—brain cancer	0.000169	0.00356	CbGeAlD
Ezetimibe—ABCG8—Metabolism—ENO2—brain cancer	0.000166	0.00263	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000165	0.00262	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000164	0.00261	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP2C9—brain cancer	0.000161	0.00256	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ENO2—brain cancer	0.000159	0.00253	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00015	0.00239	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00015	0.00238	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000143	0.00227	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000141	0.00224	CbGpPWpGaD
Ezetimibe—ABCB1—brain—brain cancer	0.000137	0.00289	CbGeAlD
Ezetimibe—UGT2B15—Metabolism—BSG—brain cancer	0.000137	0.00218	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	0.000133	0.00211	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000131	0.00208	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000123	0.00195	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000121	0.00192	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000118	0.00188	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—IDH1—brain cancer	0.000118	0.00188	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000102	0.00162	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000101	0.00161	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CG—brain cancer	0.0001	0.00159	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP2C9—brain cancer	9.87e-05	0.00157	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.73e-05	0.00155	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ENO2—brain cancer	9.33e-05	0.00148	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—CTNNB1—brain cancer	9.31e-05	0.00148	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.98e-05	0.00143	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—TRPC6—brain cancer	8.74e-05	0.00139	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP2C9—brain cancer	8.64e-05	0.00137	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	8.51e-05	0.00135	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.07e-05	0.00128	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CG—brain cancer	7.59e-05	0.00121	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP2C9—brain cancer	7.35e-05	0.00117	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—BSG—brain cancer	7.35e-05	0.00117	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP2C9—brain cancer	7.35e-05	0.00117	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CG—brain cancer	7.31e-05	0.00116	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	7.06e-05	0.00112	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	6.93e-05	0.0011	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	6.81e-05	0.00108	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.51e-05	0.00104	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.38e-05	0.00101	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—IDH1—brain cancer	6.32e-05	0.001	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—BSG—brain cancer	6.25e-05	0.000993	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—BSG—brain cancer	6.25e-05	0.000993	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	6.03e-05	0.000958	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2C9—brain cancer	5.97e-05	0.000949	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.59e-05	0.000889	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—brain cancer	5.57e-05	0.000885	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.49e-05	0.000872	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2C9—brain cancer	5.47e-05	0.00087	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.47e-05	0.000869	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.42e-05	0.000861	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—IDH1—brain cancer	5.37e-05	0.000854	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—IDH1—brain cancer	5.37e-05	0.000854	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—BSG—brain cancer	5.08e-05	0.000807	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2C9—brain cancer	5.07e-05	0.000805	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.04e-05	0.000801	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ENO2—brain cancer	5e-05	0.000794	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.8e-05	0.000763	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—brain cancer	4.73e-05	0.000752	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—BSG—brain cancer	4.65e-05	0.00074	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.37e-05	0.000695	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—IDH1—brain cancer	4.37e-05	0.000694	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—BSG—brain cancer	4.31e-05	0.000685	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CG—brain cancer	4.28e-05	0.00068	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ENO2—brain cancer	4.25e-05	0.000675	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ENO2—brain cancer	4.25e-05	0.000675	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.15e-05	0.00066	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—IDH1—brain cancer	4e-05	0.000636	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.91e-05	0.000621	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—IDH1—brain cancer	3.7e-05	0.000589	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ENO2—brain cancer	3.45e-05	0.000549	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.26e-05	0.000518	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.26e-05	0.000518	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ENO2—brain cancer	3.16e-05	0.000503	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.03e-05	0.000482	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ENO2—brain cancer	2.93e-05	0.000466	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2C9—brain cancer	2.74e-05	0.000435	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.68e-05	0.000426	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.65e-05	0.000422	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.34e-05	0.000371	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BSG—brain cancer	2.33e-05	0.00037	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CG—brain cancer	2.29e-05	0.000364	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.15e-05	0.000342	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.1e-05	0.000334	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—IDH1—brain cancer	2e-05	0.000318	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—brain cancer	1.95e-05	0.00031	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—brain cancer	1.95e-05	0.00031	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.76e-05	0.000281	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2C9—brain cancer	1.69e-05	0.000268	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—brain cancer	1.58e-05	0.000252	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ENO2—brain cancer	1.58e-05	0.000252	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—brain cancer	1.45e-05	0.000231	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BSG—brain cancer	1.44e-05	0.000228	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—brain cancer	1.34e-05	0.000214	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—IDH1—brain cancer	1.23e-05	0.000196	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENO2—brain cancer	9.75e-06	0.000155	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—brain cancer	7.26e-06	0.000115	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—brain cancer	4.47e-06	7.11e-05	CbGpPWpGaD
